Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals, 74417 [2021-28362]
Download as PDF
<![CDATA[
74417
Federal Register / Vol. 86, No. 248 / Thursday, December 30, 2021 / Notices
Committee’s mission in general.
Organizations with recommendations
on strategies to engage states and
stakeholders are encouraged to submit
their comments or resources (hyperlinks
preferred). Written comments or
statements received after January 3,
2022, may not be provided to the
Committee until its next meeting.
Verbal Statements: Pursuant to 41
CFR 102–3.140d, the Committee is not
obligated to allow a member of the
public to speak or otherwise address the
Committee during the meeting.
Members of the public are invited to
provide verbal statements during the
Committee meeting only at the time and
manner described in the agenda. The
request to speak should include a brief
statement of the subject matter to be
addressed and should be relevant to the
stated agenda of the meeting or the
Committee’s mission in general.
Minutes: The minutes of this meeting
will be available for public review and
copying within 90 days at https://
www.acf.hhs.gov/otip/partnerships/thenational-advisory-committee.
Dated: December 27, 2021.
Megan E. Steel,
Deputy Director, Executive Secretariat.
[FR Doc. 2021–28360 Filed 12–29–21; 8:45 am]
BILLING CODE 4184–40–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket Nos. FDA–2012–N–0536; FDA–
2020–N–1307; FDA–2014–N–1048; FDA–
2021–N–0356; FDA–2011–D–0147; FDA–
2018–N–1857; FDA–2021–N–0341; and
FDA–2015–N–1837]
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approvals
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is publishing a
list of information collections that have
been approved by the Office of
SUMMARY:
Management and Budget (OMB) under
the Paperwork Reduction Act of 1995.
Ila
S. Mizrachi, Office of Operations, Food
and Drug Administration, Three White
Flint North, 10A–12M, 11601
Landsdown St, North Bethesda, MD
20852, 301–796–7726, PRAStaff@
fda.hhs.gov.
FOR FURTHER INFORMATION CONTACT:
The
following is a list of FDA information
collections recently approved by OMB
under section 3507 of the Paperwork
Reduction Act of 1995 (44 U.S.C. 3507).
The OMB control number and
expiration date of OMB approval for
each information collection are shown
in table 1. Copies of the supporting
statements for the information
collections are available on the internet
at https://www.reginfo.gov/public/do/
PRAMain. An Agency may not conduct
or sponsor, and a person is not required
to respond to, a collection of
information unless it displays a
currently valid OMB control number.
SUPPLEMENTARY INFORMATION:
TABLE 1—LIST OF INFORMATION COLLECTIONS APPROVED BY OMB
OMB control
No.
Title of collection
Medical Device User Fee Cover Sheet and Device Facility User Fee Cover Sheet .............................................
Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials ....................................................................................................................................................................
Medical Device Labeling Regulations .....................................................................................................................
Establishment and Operation of Clinical Trial Data Monitoring Committees ..........................................................
Reports Intended to Demonstrate the Substantial Equivalence of a New Tobacco Product .................................
Current Good Manufacturing Practice and Hazard Analysis and Risk-Based Preventive Controls for Human
Food and Food for Animals .................................................................................................................................
Federal-State Regulatory Program Standards ........................................................................................................
Electronic User Fee Payment Form ........................................................................................................................
Dated: December 27, 2021.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2021–28362 Filed 12–29–21; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Committee on Vital and Health
Statistics
Centers for Disease Control and
Prevention, HHS.
ACTION: Notice of meeting.
khammond on DSKJM1Z7X2PROD with NOTICES
AGENCY:
Pursuant to the Federal
Advisory Committee Act, the
Department of Health and Human
Services (HHS) announces the following
advisory committee meeting. This
meeting is open to the public. The
public is welcome to obtain the link to
SUMMARY:
VerDate Sep<11>2014
17:19 Dec 29, 2021
Jkt 256001
attend this meeting by following the
instructions that will be posted on the
website prior to the meeting at: https://
ncvhs.hhs.gov/.
Name: National Committee on Vital
and Health Statistics (NCVHS), Meeting
of the full Committee.
DATES: The meeting will be held
Monday, January 24, 2022: 10:30 a.m.–
5:30 p.m. EST and Tuesday, January 25,
2021: 10:00 a.m.–4:30 p.m. EST.
ADDRESSES: Virtual open meeting.
FOR FURTHER INFORMATION CONTACT:
Substantive program information may
be obtained from Rebecca Hines, MHS,
Executive Secretary, NCVHS, National
Center for Health Statistics, Centers for
Disease Control and Prevention, 3311
Toledo Road, Hyattsville, Maryland
20782, or via electronic mail to vgh4@
cdc.gov; or by telephone (301) 458–
4715. Summaries of meetings and a
roster of Committee members are
PO 00000
Frm 00015
Fmt 4703
Sfmt 4703
Date approval
expires
0910–0511
10/31/2024
0910–0902
0910–0485
0910–0581
0910–0673
10/31/2024
11/30/2024
11/30/2024
11/30/2024
0910–0751
0910–0760
0910–0805
11/30/2024
11/30/2024
11/30/2024
available on the NCVHS website,
https://ncvhs.hhs.gov/, where further
information including an agenda and
instructions to access the broadcast of
the meeting will be posted.
Should you require reasonable
accommodation, please contact the CDC
Office of Equal Employment
Opportunity on (770) 488–3210 as soon
as possible.
SUPPLEMENTARY INFORMATION:
Purpose: As outlined in its Charter,
the National Committee on Vital and
Health Statistics assists and advises the
Secretary of HHS on health data, data
standards, statistics, privacy, national
health information policy, and the
Department’s strategy to best address
those issues. This includes the adoption
and implementation of transaction
standards, unique identifiers, operating
rules and code sets adopted under the
Health Insurance and Portability Act of
E:\FR\FM\30DEN1.SGM
30DEN1
]]>Agencies
[Federal Register Volume 86, Number 248 (Thursday, December 30, 2021)]
[Notices]
[Page 74417]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-28362]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket Nos. FDA-2012-N-0536; FDA-2020-N-1307; FDA-2014-N-1048; FDA-
2021-N-0356; FDA-2011-D-0147; FDA-2018-N-1857; FDA-2021-N-0341; and
FDA-2015-N-1837]
Agency Information Collection Activities; Announcement of Office
of Management and Budget Approvals
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is publishing a list of
information collections that have been approved by the Office of
Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations,
Food and Drug Administration, Three White Flint North, 10A-12M, 11601
Landsdown St, North Bethesda, MD 20852, 301-796-7726,
[email protected].
SUPPLEMENTARY INFORMATION: The following is a list of FDA information
collections recently approved by OMB under section 3507 of the
Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control
number and expiration date of OMB approval for each information
collection are shown in table 1. Copies of the supporting statements
for the information collections are available on the internet at
https://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or
sponsor, and a person is not required to respond to, a collection of
information unless it displays a currently valid OMB control number.
Table 1--List of Information Collections Approved by OMB
------------------------------------------------------------------------
OMB control Date approval
Title of collection No. expires
------------------------------------------------------------------------
Medical Device User Fee Cover Sheet and 0910-0511 10/31/2024
Device Facility User Fee Cover Sheet...
Examination of Secondary Claim 0910-0902 10/31/2024
Disclosures and Biosimilar Disclosures
in Prescription Drug Promotional
Materials..............................
Medical Device Labeling Regulations..... 0910-0485 11/30/2024
Establishment and Operation of Clinical 0910-0581 11/30/2024
Trial Data Monitoring Committees.......
Reports Intended to Demonstrate the 0910-0673 11/30/2024
Substantial Equivalence of a New
Tobacco Product........................
Current Good Manufacturing Practice and 0910-0751 11/30/2024
Hazard Analysis and Risk-Based
Preventive Controls for Human Food and
Food for Animals.......................
Federal-State Regulatory Program 0910-0760 11/30/2024
Standards..............................
Electronic User Fee Payment Form........ 0910-0805 11/30/2024
------------------------------------------------------------------------
Dated: December 27, 2021.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2021-28362 Filed 12-29-21; 8:45 am]
BILLING CODE 4164-01-P
